Warning letter
Overland Park Regional Medical Center: warning letter of Jul 16, 2007
FDA warning letter UCM076447 · Kansas City District Office
Key facts
| Reference number | UCM076447 |
|---|---|
| Company | Overland Park Regional Medical Center |
| Subject | CGMP/Deviations/Adulterated |
| Issue date | Jul 16, 2007 |
| Posted date | Jul 16, 2007 |
| Issuing office | Kansas City District Office |
| Product type | Biologics |
| CFR sections cited | 606.140(c), 606, 606.100(c), 606.170(a) |
| Country | 3 |
| Inspection city | Overland Park |
| Inspection ZIP | 66215-2306 |
| Inspection start date | Apr 16, 2007 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: